Auro Nair promoted to President of JAX® Mice, Clinical and Research Services
By Sarah Laskowski
Farmington, Conn. —The Jackson Laboratory (JAX), an independent, nonprofit biomedical research institution, today announced that Auro Nair, Ph.D., has been promoted to president of JAX® Mice, Clinical and Research Services.
“Auro’s decade of outstanding leadership at JAX has been marked by significant expansion of our high quality scientific tools, new products, and offerings that advance biomedical research and enhance global drug discovery,” said Edison Liu, M.D., president and CEO. “I’m very excited about Auro and his team’s potential to accelerate research and discovery, particularly in areas like immuno-oncology, humanized mice, transgenic mouse models, and clinical diagnostics.”
Dr. Nair joined The Jackson Laboratory in 2007 as associate general manager of JAX® Mice and Services. The institution then added clinical services to its offerings, and in 2011 Nair was named general manager of JAX® Clinical and Research Services, responsible for all clinical and scientific research services provided to internal researchers at The Jackson Laboratory and external researchers worldwide. In 2014 he became responsible for all mouse production and operations and was named general manager, JAX® Mice, Clinical and Research Services.
Prior to joining JAX, Nair served as vice president for worldwide marketing and North American sales with Caliper Life Sciences (today part of PerkinElmer), where he was responsible for commercialization of Caliper’s products and services. He had been with Caliper and its predecessor company, Zymark, since 1997. From 1990 to 1997 Nair managed Quality Compliance and Analytical Services at GlaxoSmithKline’s FDA-approved site in Singapore.
Nair has a degree in chemistry from the University of Science in Penang, Malaysia; holds a Ph.D. in chemistry from the University of Oklahoma, Norman; and has an Executive MBA from Suffolk University in Boston, Mass.
About The Jackson Laboratory
The Jackson Laboratory is an independent, nonprofit biomedical research institution based in Bar Harbor, Maine, with a National Cancer Institute-designated Cancer Center, a facility in Sacramento, Calif., and a genomic medicine institute in Farmington, Conn. It employs 1,800 staff, and its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health. For more information, please visit www.jax.org.